Circulating Tumor DNA Monitoring in Stage II-III Breast Cancer
Circulating tumor DNA testing shows promise predicting relapse in high-risk breast cancer, enabling earlier intervention, monitoring, and treatment adjustments that could improve survival outcomes rates.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.